The prognostic impact of psychiatric intervention on alcohol-associated liver disease: The UK Biobank cohort study
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Alcohol-associated liver disease (ALD) is a public health concern. ALD patients often have psychiatric comorbidities, but the effects of psychiatric interventions on ALD are not well-established. This study explores the prognostic impact of psychiatric intervention on ALD within UK Biobank cohort. Methods: This population-based study included 2,417 ALD patients from the UK Biobank cohort. Psychiatric intervention was defined by a consultation with psychiatrists during hospitalization or a history of medication related to alcohol use disorder and psychiatric comorbidities. Survival analysis was conducted, incorporating propensity score matching (PSM), to precisely assess the impact of psychiatric intervention. Results: Among 2,417 ALD patients, those with F10 (mental disorders due to alcohol) codes had poorer survival outcomes. Psychiatric intervention significantly improved the outcomes of both all-cause and liver-related mortality and reduced the incidence of liver cirrhosis. In subgroup or 2-year landmark analyses, psychiatric intervention consistently showed a survival benefit in ALD patients. In the multivariate analysis, psychiatric intervention was identified as a favorable prognostic factor (hazard ratio, 0.780; P=0.002 after PSM). Conclusions: This study demonstrates the favorable effect of psychiatric intervention in ALD patients with psychiatric comorbidities. These findings emphasize the importance of integrated management for ALD patients to address both their medical and psychiatric aspects. Therefore, we suggest the potential benefits of early psychiatric interventions in improving survival outcomes in ALD.
Abstract
Background/Aims: Alcohol-associated liver disease (ALD) is a public health concern. ALD patients often have psychiatric comorbidities, but the effects of psychiatric interventions on ALD are not well-established. This study explores the prognostic impact of psychiatric intervention on ALD within UK Biobank cohort. Methods: This population-based study included 2,417 ALD patients from the UK Biobank cohort. Psychiatric intervention was defined by a consultation with psychiatrists during hospitalization or a history of medication related to alcohol use disorder and psychiatric comorbidities. Survival analysis was conducted, incorporating propensity score matching (PSM), to precisely assess the impact of psychiatric intervention. Results: Among 2,417 ALD patients, those with F10 (mental disorders due to alcohol) codes had poorer survival outcomes. Psychiatric intervention significantly improved the outcomes of both all-cause and liver-related mortality and reduced the incidence of liver cirrhosis. In subgroup or 2-year landmark analyses, psychiatric intervention consistently showed a survival benefit in ALD patients. In the multivariate analysis, psychiatric intervention was identified as a favorable prognostic factor (hazard ratio, 0.780; P=0.002 after PSM). Conclusions: This study demonstrates the favorable effect of psychiatric intervention in ALD patients with psychiatric comorbidities. These findings emphasize the importance of integrated management for ALD patients to address both their medical and psychiatric aspects. Therefore, we suggest the potential benefits of early psychiatric interventions in improving survival outcomes in ALD.
참고문헌 (37)
- Seitz HK, "Alcoholic liver disease", Nat Rev Dis Primers, 4, pp.16~ (2018)
- Singal AK, "Diagnosis and treatment of alcoholassociated liver disease : a review", JAMA, 326, pp.165~176 (2021)
- Wu X, "Recent advances in understanding of pathogenesis of alcohol-associated liver disease", Annu Rev Pathol, 18, pp.411~438 (2023)
- Gómez-Medina C, "Subclinical versus advanced forms of alcohol-related liver disease : need for early detection", Clin Mol Hepatol, 29, pp.1~15 (2023)
- Crabb DW, "Diagnosis and treatment of alcohol-associated liver diseases : 2019practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 71, pp.306~333 (2020)
- European Association for the Study of the Liver, "EASL clinical practice guidelines : management of alcohol-related liver disease", J Hepatol, 69, pp.154~181 (2018)
- Roerecke M, "Reduction of alcohol consumption and subsequent mortality in alcohol use disorders : systematic review and meta-analyses", J Clin Psychiatry, 74, pp.e1181~e1189 (2013)
- Laramée P, "Risk of all-cause mortality in alcoholdependent individuals : a systematic literature review and meta-analysis", EBioMedicine, 2, pp.1394~1404 (2015)
- Ramkissoon R, "Alcohol use disorder and alcoholassociated liver disease", Alcohol Res, 42, pp.13~ (2022)
- Kranzler HR, "Diagnosis and pharmacotherapy of alcohol use disorder : a review", JAMA, 320, pp.815~824 (2018)
- Reus VI, "The American Psychiatric Association practice guideline for the pharmacological treatment of patients with alcohol use disorder", Am J Psychiatry, 175, pp.86~90 (2018)
- Carvalho AF, "Alcohol use disorders", Lancet, 394, pp.781~792 (2019)
- Blodgett JC, "A metaanalysis of topiramate’s effects for individuals with alcohol use disorders", Alcohol Clin Exp Res, 38, pp.1481~1488 (2014)
- Mason BJ, "Gabapentin treatment for alcohol dependence : a randomized clinical trial", JAMA Intern Med, 174, pp.70~77 (2014)
- Khan A, "Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease : a systematic review", Clin Gastroenterol Hepatol, 14, pp.191~202 (2016)
- Castillo-Carniglia A, "Psychiatric comorbidities in alcohol use disorder", Lancet Psychiatry, 6, pp.1068~1080 (2019)
- Winder GS, "Integrated care of alcohol-related liver disease", J Clin Exp Hepatol, 12, pp.1069~1082 (2022)
- Shaffer LR, "The association between mental illness and all-cause mortality in patients with cirrhosis : a Veterans Affairs retrospective cohort study", Hepatol Commun, 7, pp.e0129~ (2023)
- McHugh RK, "Alcohol use disorder and depressive disorders", Alcohol Res, 40, pp.arcr.v40.1.01.~ (2019)
- Collins R, "What makes UK Biobank special?", Lancet, 379, pp.1173~1174 (2012)
- Lee DU, "The clinical implication of psychiatric illnesses in patients with alcoholic liver disease : an analysis of US hospitals", Expert Rev Gastroenterol Hepatol, 16, pp.689~697 (2022)
- Petermann-Rocha F, "Associations of muscle mass and grip strength with severe NAFLD : a prospective study of 333, 295UK Biobank participants", J Hepatol, 76, pp.1021~1029 (2022)
- Petermann-Rocha F, "Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease : a prospective study of 171, 544 UK Biobank participants", BMC Med, 21, pp.123~ (2023)
- Moon AM, "Rising mortality from alcohol-associated liver disease in the United States in the 21st century", Am J Gastroenterol, 115, pp.79~87 (2020)
- Pimpin L, "Burden of liver disease in Europe : epidemiology and analysis of risk factors to identify prevention policies", J Hepatol, 69, pp.718~735 (2018)
- Asrani SK, "Reducing the global burden of alcohol-associated liver disease : a blueprint for action", Hepatology, 73, pp.2039~2050 (2021)
- Sinn DH, "Modest alcohol intake and mortality in individuals with elevated alanine aminotransferase levels : a nationwide cohort study", BMC Med, 20, pp.18~ (2022)
- Rodríguez M, "Impact of alcohol abstinence on the risk of hepatocellular carcinoma in patients with alcohol-related liver cirrhosis", Am J Gastroenterol, 116, pp.2390~2398 (2021)
- John U, "Alcohol abstinence and mortality in a general population sample of adults in Germany : a cohort study", PLoS Med, 18, pp.e1003819~ (2021)
- Rogal S, "Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis", Hepatology, 71, pp.2080~2092 (2020)
- Vannier AGL, "Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder", JAMA Netw Open, 5, pp.e2213014~ (2022)
- Hofer BS, "Alcohol abstinence improves prognosis across all stages of portal hypertension in alcohol-related cirrhosis", Clin Gastroenterol Hepatol, 21, pp.2308~2317 (2023)
- Greenfield TK, "Effects of depression and social integration on the relationship between alcohol consumption and all-cause mortality", Addiction, 97, pp.29~38 (2002)
- Perälä J, "Alcohol-induced psychotic disorder and delirium in the general population", Br J Psychiatry, 197, pp.200~206 (2010)
- Wilson JD, "Inpatient addiction medicine consultation service impact on post-discharge patient mortality : a propensitymatched analysis", J Gen Intern Med, 37, pp.2521~2525 (2022)
- Yule AM, "Integrating treatment for co-occurring mental health conditions", Alcohol Res, 40, pp.arcr.v40.1.07~ (2019)
- Holbeck M, "Integrated multidisciplinary management of alcohol-associated liver disease", J Clin Transl Hepatol, 11, pp.1404~1412 (2023)